During the past decade, 1001 South Market Street conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "1001 South Market Street" are "Primary Fibromyalgia" (2 trials). Many other conditions were trialed in "1001 South Market Street" in a lesser frequency.

Most popular intervention types in "1001 South Market Street" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "TNX-102 SL" (1 trials) and "TNX-102 SL 2.8mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "1001 South Market Street" are 2 trials for "All" genders.

Currently, there are NaN active trials in "1001 South Market Street". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in 1001 South Market Street, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in 1001 South Market Street, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".